Pharmaceutical company in
Lausanne
41 companies in Pharmaceutical company based in Lausanne — name and year of registration from the commercial register. The list below shows them all.
All 41 companies in Lausanne
Medifit MTC Sàrl
Since 2007 · 21–50 empl.4.8(64)
Medifit MTC Sàrl provides physiotherapy in clinics and through home visits. Its services include general and sports physiotherapy, rehabilitation and medical training.
Medifit effusion service Sàrl
Since 2021 · 1–10 empl.4.8(64)
Medifit effusion service Sàrl provides physiotherapy and rehabilitation services, including general and sports physiotherapy, manual therapy (Méthode SOLÈRE®) and medical training therapy (MTT). The practice also offers home physiotherapy, lymphatic drainage, oncology and geriatric rehabilitation, and therapeutic modalities such as cryotherapy, electrostimulation and shockwave therapy.
Medifit physiothérapie à domicile Sàrl
Since 2021 · 1–10 empl.4.8(64)
Medifit physiothérapie à domicile Sàrl is a provider of physiotherapy services offering rehabilitation, medical training therapy (MTT) and home-based physiotherapy. The organisation operates clinics in Lausanne, Morges and Yverdon-les-Bains and provides home care services in Vevey.
Medifit physiothérapie et sport Sàrl
Since 2021 · 1–10 empl.4.8(64)
Medifit physiothérapie et sport Sàrl is a physiotherapy centre focused on rehabilitation and sports physiotherapy. It provides clinic-based and home-care treatments, including orthopaedic, neurological and lymphatic physiotherapy, as well as medical training therapy.
Medifit Service Sàrl
Since 2021 · 1–10 empl.4.8(64)
Medifit Service Sàrl provides physiotherapy, rehabilitation and medical training services, including home physiotherapy. Offerings include sports physiotherapy, manual therapy (Méthode SOLÈRE®), Medical Training Therapy (MTT) and device-based treatments such as cryocompression, electrostimulation and shockwave therapy.
Medifit Groupe SA
Since 2023 · 1–10 empl.4.8(64)
Medifit Groupe SA provides physiotherapy services including rehabilitation, sports physiotherapy and home-based physiotherapy. Its services cover orthopaedic, neurological and geriatric rehabilitation, manual therapy (Méthode SOLÈRE®), medical training therapy (MTT) and adjunct treatments such as cryotherapy, shockwave therapy and electrostimulation.
AC Immune SA
Since 2003 · 101–500 empl.5.0(2)
AC Immune SA is a clinical-stage biopharmaceutical company developing therapies and diagnostic agents for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Its pipeline includes active immunotherapies, antibodies, small-molecule drugs and imaging agents.
FONDATION EUROVACC
Since 2002 · 11–20 empl.
FONDATION EUROVACC is a non-profit foundation that promotes research and development of vaccines against HIV and other infectious diseases. It supports the translation of research into early-phase clinical trials and collaborates with academic groups and other partners.
AMAZENTIS SA
Since 2007 · 11–20 empl.
AMAZENTIS SA is a life-sciences biotechnology company that researches Urolithin A and develops the ingredient Mitopure®. It studies applications in cellular health and develops related nutrition and skincare products, offered through its Timeline brand.
Excellness Biotech SA
Since 2009 · 1–10 empl.
Excellness Biotech SA develops and sells biomedical cell culture products, including elastic substrates that mimic the mechanical properties of human tissues. Its products support cell culture applications and the study and measurement of contraction in cells and tissue samples.
Laboratoire Pharmessence, Luc-Henri Geny
Since 2013 · 1–10 empl.
Laboratoire Pharmessence, Luc-Henri Geny manufactures and distributes medicines and plant-based products for medical use. Its range includes essential and vegetable oils, hydrolats, plant extracts, and compounded preparations for healthcare professionals.
fondation Innovative Medicines for Tuberculosis (iM4TB)
Since 2014 · 11–20 empl.
fondation Innovative Medicines for Tuberculosis (iM4TB) supports research and development of medicines to treat tuberculosis. It backs the preclinical and clinical development of drug candidates and works to bridge the gap between scientific discovery and bringing treatments to market.
Axalbion SA
Since 2017 · 11–20 empl.
Axalbion SA is a biopharmaceutical company developing AX-8, a locally delivered TRPM8 agonist for refractory chronic cough. The program is advancing toward Phase 2b development.
Tigen Pharma SA
Since 2017 · 11–20 empl.
Tigen Pharma SA is a biotechnology company developing cell therapies for cancer. Its focus includes autologous T-cell therapies, such as CAR-T and TIL approaches, and the development of a manufacturing platform for cell and gene therapies.
Orgenesis Switzerland Sàrl
Since 2020 · 11–20 empl.
Orgenesis Switzerland Sàrl develops and implements the POCare platform for cell and gene therapies, focusing on process development, validation and automated closed‑loop bioprocessing units (OMPUL™) for decentralized point‑of‑care production.
Oculis Operations Sàrl
Since 2022 · 21–50 empl.
The core activity of Oculis is the development and research of innovative treatments and medications for eye diseases, particularly in the areas of Diabetic Maculopathy, dry eye, Uveitis and acute Optic Neuritis. The company focuses on developing highly effective and patient-centered solutions to improve the treatment of eye diseases and preserve patients' vision.
Avrion Therapeutics SA
Since 2020 · 11–20 empl.
Avrion Therapeutics SA develops gene therapies for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Its work includes researching ways to protect synapses, advancing therapeutic candidates, and developing technologies to deliver therapeutic gene sequences to targeted cell types in the central nervous system.
ReproNovo SA
Since 2021 · 11–20 empl.
ReproNovo SA is a clinical-stage biopharmaceutical company developing therapies for male and female fertility and women’s health. Its development programmes target areas including sperm production, embryo implantation and the treatment of adenomyosis.
Aspeya Switzerland SA
Since 2024 · 21–50 empl.
Aspeya Switzerland SA develops and commercializes products and brands in wellness and healthcare. It applies scientific expertise and technology to develop offerings for patients and consumers.
AB2 Bio SA
Since 2010 · 11–20 empl.5.0(2)
Neurocol Operations Sàrl
Since 2025 · 1–10 empl.
Neurocol Operations Sàrl develops and advances biopharmaceutical programs for neuro-ophthalmic and ophthalmic conditions with significant unmet medical needs. Its work focuses on the clinical candidates Privosegtor and Licaminlimab and on the development of related therapies.
Laboratoire O2&VIE SA
Since 2025 · 1–10 empl.
Laboratoire O2&VIE SA develops nutritional supplements for healthcare professionals and their patients. Its products include formulations with plant-based ingredients, amino acids and vitamins for a range of metabolic needs.
Grand Medical Group AG
Since 2012 · 1–10 empl.2.0(1)
Grand Medical Group AG is a pharmaceutical group involved in the development, manufacture and registration of medicines and their introduction into medical practice. Its portfolio covers several therapeutic areas, including urology, gynaecology, cardiology, neurology and gastroenterology, and the group also provides contract manufacturing.
Baio Labs Sàrl
Since 2025 · 1–10 empl.
Biodelphis Therapeutics SA
Since 2026 · 1–10 empl.
Biodelphis Therapeutics SA develops antibody-peptide conjugates as targeted protease inhibitors for drug therapies. Its preclinical pipeline includes drug candidates targeting cathepsins, with potential applications in oncology and osteoporosis.
SwissNovaGene Sàrl
Since 2026 · 1–10 empl.
SwissNovaGene Sàrl is a biotechnology company focused on combinatorial micronutrition. It develops and distributes dietary supplements with combined micronutrient formulas tested in human clinical trials and designed to support functions including sleep, immunity, stress regulation, metabolism, physical performance and recovery.
ABRA Sàrl
Since 2010 · 1–10 empl.
The core activity of Abra-Pharma is to advise and support pharmaceutical, bio-pharmaceutical and biotechnology companies in the market authorization and launch of their medicines in Switzerland and the EU. This includes services such as regulatory approval consulting, market access, sales and distribution of medicines. Additionally, the company researches natural solutions for various diseases and offers innovative medical products, such as wound healing solutions and blood volume analyzers.
CHRONDEL SA
Since 2015 · 1–10 empl.
OrBioteK Sàrl
Since 2016 · 1–10 empl.
ECS-Progastrin SA
Since 2016 · 1–10 empl.
COMBISIN Sàrl
Since 2017 · 1–10 empl.
TATWA Sàrl
Since 2018 · 1–10 empl.
Sénèque SA
Since 2018 · 1–10 empl.
Imalia SA
Since 2022 · 1–10 empl.
OSASUNA Therapeutics SA
Since 2022 · 1–10 empl.
Beech Biotech SA
Since 2022 · 1–10 empl.
Leman Biotech Lausanne SA
Since 2022 · 1–10 empl.
SwitchKine SA
Since 2023 · 1–10 empl.
EpiCure Biotechnologies SA
Since 2024 · 1–10 empl.
HepaVue Dx Sàrl
Since 2024 · 1–10 empl.
Juvion Health Sciences SA
Since 2024 · 1–10 empl.
Pharmaceutical company in Lausanne
Pharmaceutical company in other places
By canton